Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
BMC Cancer|November 18, 2015
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutationsKatsuhiro Masago, Shiro Fujita, Miho Muraki, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|February 27, 2016
Dose reduction in cone-beam CT scanning for intracranial stent deployment before coil embolization of intracranial wide-neck aneurysmsTakumi Kuriyama, Nobuyuki Sakai, Norimitsu Niida, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2015
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non-Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKIAkito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, et al.
Oncotarget|January 27, 2018
Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancerAkito Hata, Nobuyuki Katakami, Shigeki Nanjo, et al.
Clinical Lung Cancer|July 22, 2011
Plasma and pleural fluid pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small-cell lung cancer with pleural effusionKatsuhiro Masago, Yosuke Togashi, Masahide Fukudo, et al.
Journal of Neuro-Oncology|April 23, 2024
Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing dataTakanari Okamoto, Ryo Mizuta, Yoshinobu Takahashi, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2011
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.
Oncology Reports|August 2, 2011
Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancerKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2010
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancerKatsuhiro Masago, Shiro Fujita, Young Hak Kim, et al.
Oncology Letters|August 7, 2012
Association between brain natriuretic peptide and distant metastases in advanced non-small cell lung cancer patientsKatsuhiro Masago, Shiro Fujita, Yosuke Togashi, et al.
Pageof 13